Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
Adipotide (FTPP)
Preclinical
Research chemical
Summary
Experimental peptidomimetic that targets prohibitin on white adipose vasculature, designed to trigger apoptosis of fat-blood-supply cells and reduce fat mass in animal models.
Categories
Metabolic & Body Comp
Mechanism
Homes to prohibitin-expressing adipose vasculature; pro-apoptotic domain disrupts mitochondrial membranes of targeted endothelial cells leading to white fat regression.
Half-life
Research-dependent
Routes
Subcutaneous injection
Legal / access
Experimental. Not approved for weight loss. Renal safety concerns historically noted.
Key risks
- Renal toxicity signals in development
- Injection reactions
- Unknown human safety
Common claims
- Targeted fat loss
- 'Fat-killing peptide' narratives
Select peptide B